Exosome Augmentation Technologies for Drug Delivery and Disease Treatment: A Review
Source abstract
Abstract
Exosomes are nanovesicles secreted by cells to exchange materials and information. Recent studies have revealed that these modified nanovesicles can be powerful tools for the diagnosis and treatment of diseases. However, few studies have reported on the acquisition and application of these functionalized exosomes. Therefore, this study provides a systematic summary of the entire process of isolation, functionalization, modification, and application of enhanced exosomes and recent progress in this field. First, the process of exosome production and principles of disease treatment are elucidated. Thereafter, the methods of exosome isolation are summarized, with a focus on improved technology centered on aptamer technology and new technology represented by microfluidics. Next, the functional modifications of the exosomes are classified and summarized. Finally, new breakthroughs in the diagnostic and therapeutic capabilities of function-enhancing exosomes compared with those of traditional exosomes are summarized, especially in terms of how these exosomes can be used in bioimaging, photothermal therapy, and other means of achieving a quantum leap in detection and therapeutic efficacy. This paper summarizes the latest research findings on engineered exosomes, with a particular focus on emerging technologies such as microfluidics and aptamers that hold significant potential. It provides a thorough analysis of their respective advantages and limitations, aiming to offer actionable insights for the future advancement and more complex applications of exosomes.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Selenium in Biological Systems · Silymarin and Mushroom Poisoning
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The First Affiliated Hospital of Wenzhou Medical University
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, Zhejiang 310015, China.
Funding
the Natural Science Foundation of Hangzhou
References (100+)
Show source-provided references
1. 10.7150/thno.4158010.7150/thno.41580 ↗
2. 10.3389/fphar.2021.67116410.3389/fphar.2021.671164 ↗
3. 10.3389/fvets.2021.65406410.3389/fvets.2021.654064 ↗
4. 10.7150/thno.5400410.7150/thno.54004 ↗
5. Yang B, Chen Y, Shi J. Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms. Adv Mater. 2018;31(2): Article e1802896.10.1002/adma.201802896 ↗
6. 10.7150/thno.2194510.7150/thno.21945 ↗
7. 10.1016/j.lfs.2024.12301910.1016/j.lfs.2024.123019 ↗
8. 10.1155/2022/700628110.1155/2022/7006281 ↗
9. 10.1186/s12943-019-1085-010.1186/s12943-019-1085-0 ↗
10. 10.1016/j.mtbio.2025.10253810.1016/j.mtbio.2025.102538 ↗
11. 10.4155/fmc-2018-041710.4155/fmc-2018-0417 ↗
12. 10.14348/molcells.2022.203310.14348/molcells.2022.2033 ↗
13. 10.1021/acsnano.1c0346910.1021/acsnano.1c03469 ↗
14. 10.1016/j.jconrel.2022.05.02710.1016/j.jconrel.2022.05.027 ↗
15. 10.1002/jev2.1213010.1002/jev2.12130 ↗
16. 10.1111/brv.1260810.1111/brv.12608 ↗
17. 10.2147/IJN.S28189010.2147/IJN.S281890 ↗
18. 10.1016/j.biomaterials.2022.12194910.1016/j.biomaterials.2022.121949 ↗
19. 10.3390/molecules2604113510.3390/molecules26041135 ↗
20. 10.1016/j.biomaterials.2022.12138410.1016/j.biomaterials.2022.121384 ↗
21. 10.1016/j.tcb.2023.06.00610.1016/j.tcb.2023.06.006 ↗
22. Makarova KS Tobiasson V Wolf YI Lu Z Liu Y Zhang S Krupovic M Li M Koonin EV. Diversity origin and evolution of the ESCRT systems. bioRxiv. 2024. https://doi.org/10.1101/2024.02.06.57914810.1101/2024.02.06.579148 ↗
23. 10.1016/j.virol.2014.05.00510.1016/j.virol.2014.05.005 ↗
24. 10.1126/sciadv.adg391310.1126/sciadv.adg3913 ↗
25. 10.1083/jcb.20190411310.1083/jcb.201904113 ↗
26. 10.1016/j.drudis.2021.03.02510.1016/j.drudis.2021.03.025 ↗
27. 10.1186/s13041-021-00776-910.1186/s13041-021-00776-9 ↗
28. 10.1038/s41422-020-00409-110.1038/s41422-020-00409-1 ↗
29. 10.1182/blood.202101099510.1182/blood.2021010995 ↗
30. 10.1002/advs.20180131310.1002/advs.201801313 ↗
31. 10.1242/jcs.26088710.1242/jcs.260887 ↗
32. 10.15252/embj.201910258610.15252/embj.2019102586 ↗
33. 10.3390/cells807072710.3390/cells8070727 ↗
34. 10.1186/s12951-023-01862-x10.1186/s12951-023-01862-x ↗
35. 10.1186/s12951-023-01942-y10.1186/s12951-023-01942-y ↗
36. 10.1038/s41419-022-05305-710.1038/s41419-022-05305-7 ↗
37. Su T, Xiao Y, Xiao Y, Guo Q, Li C, Huang Y, Deng Q, Wen J, Zhou F, Luo X-H. Bone marrow mesenchymal stem cells-derived exosomal MiR-29b-3p regulates aging-associated insulin resistance. ACS Nano. 2019;13(2):2450–2462.
38. 10.1016/j.jot.2023.02.00110.1016/j.jot.2023.02.001 ↗
39. 10.7554/eLife.8449310.7554/eLife.84493 ↗
40. 10.1186/s13046-023-02619-y10.1186/s13046-023-02619-y ↗
41. 10.1186/s12943-021-01471-y10.1186/s12943-021-01471-y ↗
42. 10.1016/j.cjca.2020.01.01310.1016/j.cjca.2020.01.013 ↗
43. 10.1016/j.bmt.2024.11.00110.1016/j.bmt.2024.11.001 ↗
44. 10.1007/978-1-62703-453-1_310.1007/978-1-62703-453-1_3 ↗
45. 10.1038/s41392-021-00805-y10.1038/s41392-021-00805-y ↗
46. 10.3389/fimmu.2022.94635810.3389/fimmu.2022.946358 ↗
47. 10.3389/fcimb.2023.120047810.3389/fcimb.2023.1200478 ↗
48. 10.1021/acsnano.3c0922010.1021/acsnano.3c09220 ↗
49. 10.7150/thno.6422910.7150/thno.64229 ↗
50. 10.7150/thno.3387210.7150/thno.33872 ↗
51. 10.1186/s12951-023-02065-010.1186/s12951-023-02065-0 ↗
52. 10.1186/s13287-023-03345-010.1186/s13287-023-03345-0 ↗
53. 10.1016/j.jconrel.2023.03.01310.1016/j.jconrel.2023.03.013 ↗
54. 10.1016/j.kint.2021.05.03910.1016/j.kint.2021.05.039 ↗
55. 10.1016/j.compositesb.2024.11161810.1016/j.compositesb.2024.111618 ↗
56. 10.1016/j.cej.2025.16632210.1016/j.cej.2025.166322 ↗
57. 10.3168/jds.2019-1750110.3168/jds.2019-17501 ↗
58. 10.1186/s12951-024-02603-410.1186/s12951-024-02603-4 ↗
59. 10.1186/s13287-021-02697-910.1186/s13287-021-02697-9 ↗
60. 10.1016/j.biopha.2022.11346310.1016/j.biopha.2022.113463 ↗
61. 10.2147/IJN.S48090110.2147/IJN.S480901 ↗
62. 10.1186/s12951-021-00894-510.1186/s12951-021-00894-5 ↗
63. 10.1016/j.jconrel.2023.01.07110.1016/j.jconrel.2023.01.071 ↗
64. 10.1016/j.actbio.2021.12.03510.1016/j.actbio.2021.12.035 ↗
65. 10.1186/s12951-024-02627-w10.1186/s12951-024-02627-w ↗
66. 10.1016/j.kint.2023.12.00710.1016/j.kint.2023.12.007 ↗
67. 10.1186/s11658-023-00425-010.1186/s11658-023-00425-0 ↗
68. 10.7150/thno.5455010.7150/thno.54550 ↗
69. 10.1016/j.redox.2023.10265510.1016/j.redox.2023.102655 ↗
70. 10.1002/smll.20230868010.1002/smll.202308680 ↗
71. 10.1016/j.annonc.2021.01.07410.1016/j.annonc.2021.01.074 ↗
72. 10.1002/advs.20250541310.1002/advs.202505413 ↗
73. 10.1186/s12943-021-01352-410.1186/s12943-021-01352-4 ↗
74. 10.1186/s12931-023-02423-410.1186/s12931-023-02423-4 ↗
75. 10.1038/s41598-019-39882-z10.1038/s41598-019-39882-z ↗
76. 10.1016/j.devcel.2023.01.00610.1016/j.devcel.2023.01.006 ↗
77. 10.1186/s12943-020-01235-010.1186/s12943-020-01235-0 ↗
78. 10.1158/1078-0432.CCR-24-193410.1158/1078-0432.CCR-24-1934 ↗
79. 10.1016/j.biomaterials.2013.11.08310.1016/j.biomaterials.2013.11.083 ↗
80. 10.1016/j.jconrel.2015.09.03110.1016/j.jconrel.2015.09.031 ↗
81. 10.1016/j.drup.2022.10091510.1016/j.drup.2022.100915 ↗
82. 10.1186/s12951-019-0563-210.1186/s12951-019-0563-2 ↗
83. 10.34133/bmr.014810.34133/bmr.0148 ↗
84. 10.1016/j.biomaterials.2020.12054610.1016/j.biomaterials.2020.120546 ↗
85. 10.1186/s12943-022-01515-x10.1186/s12943-022-01515-x ↗
86. 10.21037/sci-2022-03010.21037/sci-2022-030 ↗
87. 10.1016/j.ymthe.2023.06.00510.1016/j.ymthe.2023.06.005 ↗
88. 10.3389/fimmu.2018.0073810.3389/fimmu.2018.00738 ↗
89. 10.1186/s13045-020-00987-y10.1186/s13045-020-00987-y ↗
90. 10.1007/978-1-0716-2341-1_810.1007/978-1-0716-2341-1_8 ↗
91. 10.1182/blood.V74.5.1844.184410.1182/blood.V74.5.1844.1844 ↗
92. 10.3402/jev.v2i0.1986110.3402/jev.v2i0.19861 ↗
93. 10.1186/s13195-022-01133-110.1186/s13195-022-01133-1 ↗
94. 10.1080/20013078.2018.144013210.1080/20013078.2018.1440132 ↗
95. 10.3390/foods1103031310.3390/foods11030313 ↗
96. 10.1016/j.ijpharm.2019.06.02810.1016/j.ijpharm.2019.06.028 ↗
97. 10.1002/jev2.1240410.1002/jev2.12404 ↗
98. 10.3402/jev.v4.2950910.3402/jev.v4.29509 ↗
99. 10.1021/acssensors.4c0001110.1021/acssensors.4c00011 ↗
100. 10.1016/j.mtbio.2022.10052110.1016/j.mtbio.2022.100521 ↗